Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-03-01 5:14 pm Purchase | 13D | IRONWOOD PHARMACEUTICALS INC C IRWD | Sarissa Capital Management LP | 14,927,844 9.3% | 14,927,844 (New Position) | View |
2021-02-12 2:55 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BROWN CAPITAL MANAGEMENT LLC | 20,150,463 12.59% | 2,249,410 (+12.57%) | View |
2021-02-12 09:51 am Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | UBS ASSET MANAGEMENT AMERICAS INC | 1,935,957 1.21% | -9,245,494 (-82.69%) | View |
2021-02-11 1:54 pm Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | JANUS HENDERSON GROUP PLC JHG | 0 0% | -8,289,895 (Position Closed) | View |
2021-02-10 11:10 am Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 15,892,347 9.93% | -746,594 (-4.49%) | View |
2021-02-04 09:45 am Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | WELLINGTON MANAGEMENT GROUP LLP | 21,653,549 13.53% | -124,152 (-0.57%) | View |
2021-01-29 5:23 pm Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BlackRock Inc. BLK | 13,044,650 8.1% | -496,895 (-3.67%) | View |
2021-01-06 7:25 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | WESTFIELD CAPITAL MANAGEMENT CO LP | 8,488,042 5.3% | 8,488,042 (New Position) | View |
2020-11-10 10:27 am Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | FMR LLC | 2,807,589 1.748% | -8,545,905 (-75.27%) | View |
2020-11-09 09:59 am Sale | 13D | IRONWOOD PHARMACEUTICALS INC C IRWD | Sarissa Capital Management LP | 0 0% | -12,493,000 (Position Closed) | View |
2020-02-26 5:02 pm Purchase | 13D | IRONWOOD PHARMACEUTICALS INC C IRWD | Sarissa Capital Management LP | 12,493,000 7.9% | 3,000,800 (+31.61%) | View |
2020-02-14 3:14 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | JANUS HENDERSON GROUP PLC JHG | 8,289,895 5.3% | 1,635,089 (+24.57%) | View |
2020-02-14 09:33 am Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BROWN CAPITAL MANAGEMENT LLC | 17,901,053 11.42% | 740,272 (+4.31%) | View |
2020-02-12 10:12 am Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | UBS ASSET MANAGEMENT AMERICAS INC | 11,181,451 7.13% | 2,589,772 (+30.14%) | View |
2020-02-11 7:24 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 16,638,941 10.61% | 991,206 (+6.33%) | View |
2020-02-07 11:22 am Sale | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | FMR LLC | 11,353,494 7.214% | -3,518,872 (-23.66%) | View |
2020-02-05 12:16 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BlackRock Inc. BLK | 13,541,545 8.6% | 1,223,980 (+9.94%) | View |
2020-01-28 11:02 am Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | WELLINGTON MANAGEMENT GROUP LLP | 21,777,701 13.89% | 2,177,632 (+11.11%) | View |
2019-09-09 09:10 am Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BROWN CAPITAL MANAGEMENT LLC | 17,160,781 10.97% | 7,031,450 (+69.42%) | View |
2019-06-10 1:14 pm Purchase | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 15,647,735 10.05% | 2,287,181 (+17.12%) | View |